Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

PACSHealth Showcases DoseMonitor Upgrade at Chicago Trade Show

By Medimaging International staff writers
Posted on 27 Nov 2017
Print article
Image: The latest version of DoseMonitor is being shown by PACSHealth at RSNA 2017 (Photo courtesy of PACSHealth).
Image: The latest version of DoseMonitor is being shown by PACSHealth at RSNA 2017 (Photo courtesy of PACSHealth).
PACSHealth, LLC (Scottsdale, Arizona, USA), a developer of medical imaging informatics software, showcased the upgraded DoseMonitor version 2.5.2, at the annual meeting of RSNA (Radiological Society of North America), held from November 26th through November 30th in Chicago, Illinois.

DoseMonitor is an automated, enterprise-wide, vendor neutral patient radiation dose data collection, aggregation and reporting system. It identifies patients who may be at risk for ionizing radiation overexposure based on customer-provided thresholds and guidelines. By managing radiation dose effectively, facilities can adapt to new technologies and meet evolving regulatory standards and operations compliance requirements.

The latest version adds improved analytics, new interactive reporting graphics, post-procedure Peak Skin Dose (PSD) calculations and visualization for interventional radiology, CT/MR contrast data management, and exclusive support for non-ionizing modalities such as MRI.

In addition to these new features, DoseMonitor continues to lead in pre-exam organ dose modeling tools using both NCICT Phantoms and Virtual Phantoms. In 2016, DoseMonitor was the first to incorporate the National Institutes of Health (NIH) National Cancer Institute (NCI) dosimetry system for computed tomography (NCICT).

"We have incorporated these industry leading features into DoseMonitor to assist customers with regulatory compliance while providing accurate and efficient diagnostic imaging procedures," said Mike Battin, COO of PACSHealth.


Print article
Radcal

Channels

Copyright © 2000-2017 Globetech Media. All rights reserved.